# Sepsis & Septic Shock – Landmark Trials

## Rivers et al. – Early Goal-Directed Therapy (2001)
**Journal:** NEJM  
**Design:** Randomized, single-center, n=263  
**Population:** Severe sepsis and septic shock  
**Intervention:** Early goal-directed therapy protocol  
**Comparator:** Standard care  
**Primary Outcome:** In-hospital mortality  
**Key Results:** Mortality reduced in intervention group  
**Key Limitations:** Single-center, outdated standard care  
**Reference:** Rivers E et al. NEJM 2001. PubMed

## ARISE Trial (2014)
**Journal:** NEJM  
**Design:** Multicenter RCT, n=1600  
**Population:** Early septic shock  
**Intervention:** EGDT protocol  
**Comparator:** Usual care  
**Primary Outcome:** 90-day mortality  
**Key Results:** No significant difference  
**Key Limitations:** Modern care improvements may explain results  
**Reference:** ARISE Investigators, NEJM 2014. PubMed

## PROCESS Trial (2014)
**Journal:** NEJM  
**Design:** Multicenter RCT, n=1341  
**Population:** Early septic shock  
**Intervention:** EGDT  
**Comparator:** Standard care  
**Primary Outcome:** 60-day mortality  
**Key Results:** Mortality similar between groups  
**Reference:** PROCESS Investigators, NEJM 2014. PubMed

## PROMISE Trial (2015)
**Journal:** NEJM  
**Design:** Multicenter RCT, n=1260  
**Population:** Septic shock  
**Intervention:** EGDT protocol  
**Comparator:** Usual care  
**Primary Outcome:** 90-day mortality  
**Key Results:** No mortality benefit  
**Reference:** PROMISE Investigators, NEJM 2015. PubMed

## ProCESS / ARISE / PROMISE Summary
Modern RCTs show **EGDT offers no additional mortality benefit** over contemporary standard care.

